Pharmafile Logo

Shanghai Green Valley

- PMLiVE

China weighs heavy on GSK figures in Q3

Pharma company loses two thirds of sales in region after scandal-hit period

- PMLiVE

Lilly enters cancer collaboration in China

Signs deal with Chi-Med to develop and commercialise fruquintinib

Unravelling China’s healthcare sector

How will health reforms, the tightening of regulations and the emergence of a domestic drug industry impact global pharmaceutical companies?

- PMLiVE

GSK’s Chinese sales hit by scandal, say analysts

Company estimated to have lost a third of its revenues

Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market

This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in...

Research Partnership

China flag thumb

Novartis’ Alcon unit diverted trial money for bribes, claims paper

21st Century Business Herald publishes more allegations of corruption in China

- PMLiVE

US turns spotlight on GSK bribery allegations

Department of Justice to investigate whether pharma giant contravened foreign corruption act

China flag thumb

GSK blamed for employee bribes in China

Xinhua news agency claims company was complicit in the payment of kickbacks to doctors

- PMLiVE

Takeda continues Actos resurrection as Alzheimer’s drug

Late-stage trial will see if pioglitazone can delay disease progression

Eli Lilly HQ

Lilly is latest drugmaker drawn into China crisis

Local media reports link the pharma company to doctor bribery

China flag thumb

UK-US risk investigator team arrested in China

Corporate investigators with possible links to GSK detained

Novartis building

Novartis drawn into Chinese corruption probe

Former sales rep files bribery complaint about Sandostatin LAR prescribing practices

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links